[HTML][HTML] Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations …

B Fischer, T Robinson, C Bullen, V Curran… - International Journal of …, 2022 - Elsevier
Background Cannabis use is common, especially among young people, and is associated
with risks for various health harms. Some jurisdictions have recently moved to …

Improving outcomes of first‐episode psychosis: an overview

P Fusar‐Poli, PD McGorry, JM Kane - World psychiatry, 2017 - Wiley Online Library
Outcomes of psychotic disorders are associated with high personal, familiar, societal and
clinical burden. There is thus an urgent clinical and societal need for improving those …

Cannabis use among US adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates

CJ Hammond, A Chaney, B Hendrickson… - International review of …, 2020 - Taylor & Francis
Decriminalization, medicalization, and legalization of cannabis use by a majority of US
states over the past 25 years have dramatically shifted societal perceptions and use patterns …

[图书][B] The science of marijuana

LL Iversen - 2001 - books.google.com
After alcohol and nicotine, marijuana is the most commonly used" recreational" drug in
Western countries. There has already been a growing debate about the medical …

Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial

S Bhattacharyya, R Wilson, E Appiah-Kusi… - Jama …, 2018 - jamanetwork.com
Importance Cannabidiol (CBD) has antipsychotic effects in humans, but how these are
mediated in the brain remains unclear. Objective To investigate the neurocognitive …

Cannabidiol as a potential treatment for psychosis

C Davies, S Bhattacharyya - Therapeutic advances in …, 2019 - journals.sagepub.com
Psychotic disorders such as schizophrenia are heterogeneous and often debilitating
conditions that contribute substantially to the global burden of disease. The introduction of …

Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition

M Colizzi, S Bhattacharyya - Current Addiction Reports, 2017 - Springer
Abstract Purpose of Review The lack of clarity about the effect of cannabis use on cognition
may be attributable to the considerable heterogeneity among studies in terms of cannabis …

[HTML][HTML] Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis

T Schoeler, N Petros, M Di Forti, E Klamerus… - The Lancet …, 2017 - thelancet.com
Background Cannabis use following the onset of first-episode psychosis has been linked to
both increased risk of relapse and non-adherence with antipsychotic medication. Whether …

Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis

DC D'Souza, M DiForti, S Ganesh… - The World Journal of …, 2022 - Taylor & Francis
Objectives The liberalisation of cannabis laws, the increasing availability and potency of
cannabis has renewed concern about the risk of psychosis with cannabis. Methods The …

Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance

AJ Narayan, LA Downey, B Manning… - … & Biobehavioral Reviews, 2022 - Elsevier
Cannabidiol's (CBD) safety profile and broad action has made it a popular treatment option
for anxiety and co-occurring sleep disturbance. However, its efficacy in healthy and clinical …